Skip to main content
SpringerLink
Log in

Transgenics

  • Chapter
In Vivo Models of Inflammation

Part of the book series: Progress in Inflammation Research ((PIR))

  • 909 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Zambrowicz BP, Sands AT (2003) Knockouts model the 100 best-selling drugs — will they model the next 100? Nat Rev Drug Discov 2: 38–51

    Article  PubMed  CAS  Google Scholar 

  2. Nagy A, Gertsenstein M, Vintersten K, Behringer R (2002) Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor

    Google Scholar 

  3. Wolfer DP, Crusio WE, Lipp HP (2002) Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25: 336–340

    Article  PubMed  CAS  Google Scholar 

  4. Schonig K, Schwenk F, Rajewsky K, Bujard H (2002) Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res 30: e134

    Article  PubMed  Google Scholar 

  5. Copeland NG, Jenkins NA, Court DL (2001) Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2: 769–779

    Article  PubMed  CAS  Google Scholar 

  6. Yang Y, Seed B (2003) Site-specific gene targeting in mouse embryonic stem cells with intact bacterial artificial chromosomes. Nat Biotechnol 21: 447–451

    Article  PubMed  CAS  Google Scholar 

  7. Branda CS, Dymecki SM (2004) Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6: 7–28

    Article  PubMed  CAS  Google Scholar 

  8. Sauer B, Henderson N (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85: 5166–5170

    Article  PubMed  CAS  Google Scholar 

  9. Cox MM (1983) The FLP protein of the yeast 2-microns plasmid: expression of a eukaryotic genetic recombination system in Escherichia coli. Proc Natl Acad Sci USA 80: 4223–4227

    Article  PubMed  CAS  Google Scholar 

  10. Korfhagen TR, Swantz RJ, Wert SE, McCarty JM, Kerlakian CB, Glasser SW, Whitsett JA (1994) Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest 93: 1691–1699

    PubMed  CAS  Google Scholar 

  11. Elias JA, Zhu Z, Chupp G, Homer RJ (1999) Airway remodeling in asthma. J Clin Invest 104: 1001–1006

    PubMed  CAS  Google Scholar 

  12. Toniatti C, Bujard H, Cortese R, Ciliberto G (2004) Gene therapy progress and prospects: transcription regulatory systems. Gene Ther 11: 649–657

    Article  PubMed  CAS  Google Scholar 

  13. Ryding AD, Sharp MG, Mullins JJ (2001) Conditional transgenic technologies. J Endocrinol 171: 1–14

    Article  PubMed  CAS  Google Scholar 

  14. Seibler J, Zevnik B, Kuter-Luks B, Andreas S, Kern H, Hennek T, Rode A, Heimann C, Faust N, Kauselmann G et al (2003) Rapid generation of inducible mouse mutants. Nucleic Acids Res 31: e12

    Article  PubMed  CAS  Google Scholar 

  15. Weber W, Rimann M, Spielmann M, Keller B, Daoud-El Baba M, Aubel D, Weber CC, Fussenegger M (2004) Gas-inducible transgene expression in mammalian cells and mice. Nat Biotechnol 22: 1440–1444

    Article  PubMed  CAS  Google Scholar 

  16. Baer A, Bode J (2001) Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. Curr Opin Biotechnol 12: 473–480

    Article  PubMed  CAS  Google Scholar 

  17. Shmerling D, Danzer C, Mao X, Boisclair J, Haffner M, Lemaistre M, Schuler V, Kaeslin E, Korn R, Bürki K et al (2005) Strong and ubiquitous expression of transgenes targeted into the beta-actin locus by Cre/lox cassette replacement. Genesis 42: 229–235

    Article  PubMed  CAS  Google Scholar 

  18. Mittal V (2004) Improving the efficiency of RNA interference in mammals. Nat Rev Genet 5: 355–365

    Article  PubMed  CAS  Google Scholar 

  19. Oberdoerffer P, Kanellopoulou C, Heissmeyer V, Paeper C, Borowski C, Aifantis I, Rao A, Rajewsky K (2005) Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages. Mol Cell Biol 25: 3896–3905

    Article  PubMed  CAS  Google Scholar 

  20. Seibler J, Kuter-Luks B, Kern H, Streu S, Plum L, Mauer J, Kuhn R, Bruning JC, Schwenk F (2005) Single copy shRNA configuration for ubiquitous gene knockdown in mice. Nucleic Acids Res 33: e67

    Article  PubMed  Google Scholar 

  21. Eggan K, Akutsu H, Loring J, Jackson-Grusby L, Klemm M, Rideout WM 3rd, Yanagimachi R, Jaenisch R (2001) Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci USA 98: 6209–6214

    Article  PubMed  CAS  Google Scholar 

  22. Shah K, Jacobs A, Breakefield XO, Weissleder R (2004) Molecular imaging of gene therapy for cancer. Gene Ther 11: 1175–1187

    Article  PubMed  CAS  Google Scholar 

  23. Ntziachristos V, Ripoll J, Wang LV, Weissleder R (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 23: 313–230

    Article  PubMed  CAS  Google Scholar 

  24. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811–822

    Article  PubMed  CAS  Google Scholar 

  25. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1997) A new mouse model of rheumatoid arthritis: organ-specific disease provoked by systemic autoimmunity. Ryumachi 37: 147

    PubMed  CAS  Google Scholar 

  26. Matsumoto I, Staub A, Benoist C, Mathis D (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286: 1732–1735

    Article  PubMed  CAS  Google Scholar 

  27. Ji H, Gauguier D, Ohmura K, Gonzalez A, Duchatelle V, Danoy P, Garchon HJ, Degott C, Lathrop M, Benoist C et al (2001) Genetic influences on the end-stage effector phase of arthritis. J Exp Med 194: 321–330

    Article  PubMed  CAS  Google Scholar 

  28. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387–398

    Article  PubMed  CAS  Google Scholar 

  29. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253–261

    Article  PubMed  CAS  Google Scholar 

  30. Gaetke LM, Oz HS, Frederich RC, McClain CJ (2003) Anti-TNF-alpha antibody normalizes serum leptin in IL-2 deficient mice. J Am Coll Nutr 22: 415–420

    PubMed  CAS  Google Scholar 

  31. Baumgart DC, Olivier WA, Reya T, Peritt D, Rombeau JL, Carding SR (1998) Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL2)-deficient mice. Cell Immunol 187: 52–66

    Article  PubMed  CAS  Google Scholar 

  32. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263–274

    Article  PubMed  CAS  Google Scholar 

  33. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM (1996) T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184: 241–251

    Article  PubMed  CAS  Google Scholar 

  34. Sligh JE Jr, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, Beaudet AL (1993) Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 90: 8529–8533

    Article  PubMed  CAS  Google Scholar 

  35. Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T et al (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114: 582–588

    Article  PubMed  CAS  Google Scholar 

  36. Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Buschenfelde KH, Strober W, Kollias G (1997) Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 27: 1743–1750

    PubMed  CAS  Google Scholar 

  37. Campbell IK, O’Donnell K, Lawlor KE, Wicks IP (2001) Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest 107: 1519–1527

    PubMed  CAS  Google Scholar 

  38. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ et al (2000) Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106: 951–961

    PubMed  CAS  Google Scholar 

  39. Allende ML, Dreier JL, Mandala S, Proia RL (2004) Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 279: 15396–15401

    Article  PubMed  CAS  Google Scholar 

  40. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355–360

    Article  PubMed  CAS  Google Scholar 

  41. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P et al (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277: 21453–21457

    Article  PubMed  CAS  Google Scholar 

  42. Brinkmann V, Cyster JG, Hla T (2004) FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4: 1019–1025

    Article  PubMed  CAS  Google Scholar 

  43. Hayry P, Mennander A, Yilmaz S, Ustinov J, Raisanen A, Miettinen A, Lautenschlager I, Lemstrom K, Bruggeman CA, Paavonen T (1992) Towards understanding the pathophysiology of chronic rejection. Clin Investig 70: 780–790

    Article  PubMed  CAS  Google Scholar 

  44. Ross R (1999) Atherosclerosis — an inflammatory disease. N Engl J Med 340: 115–126

    Article  PubMed  CAS  Google Scholar 

  45. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403–409

    Article  PubMed  CAS  Google Scholar 

  46. Matsumoto Y, Hof A, Baumlin Y, Muller M, Prescott MF, Hof RP (2003) Dynamics of medial smooth muscle changes after carotid artery transplantation in transgenic mice expressing green fluorescent protein. Transplantation 76: 1569–1572

    Article  PubMed  Google Scholar 

  47. Mohrs M, Shinkai K, Mohrs K, Locksley RM (2001) Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15: 303–311

    Article  PubMed  CAS  Google Scholar 

  48. Shinkai K, Mohrs M, Locksley RM (2002) Helper T cells regulate type-2 innate immunity in vivo. Nature 420: 825–829

    Article  PubMed  CAS  Google Scholar 

  49. Gessner A, Mohrs K, Mohrs M (2005) Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 174: 1063–1072

    PubMed  CAS  Google Scholar 

  50. Luyten M, Hofmann M, Kaeslin E, Klanke B, Pally C, Kawai R, Zerwes H (2004) A mouse model to assess endothelial activation in vivo by targeted insertion of alkaline phosphatase into the E-selecin gene. Drug Development Res 63: 54–65

    Article  CAS  Google Scholar 

  51. Nakajima A, Seroogy CM, Sandora MR, Tarner IH, Costa GL, Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG (2001) Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 107: 1293–1301

    Article  PubMed  CAS  Google Scholar 

  52. Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, Slavin AJ, Contag CH, Fathman CG, Benson JM (2001) Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 167: 2379–2387

    PubMed  CAS  Google Scholar 

  53. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R (2002) In vivo imaging of NF-kappa B activity. J Immunol 168: 1441–1446

    PubMed  CAS  Google Scholar 

  54. Carlsen H, Alexander G, Austenaa LM, Ebihara K, Blomhoff R (2004) Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat Res 551: 199–211

    PubMed  CAS  Google Scholar 

  55. Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH (2001) Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 29: 1353–1360.

    Article  PubMed  CAS  Google Scholar 

  56. Sadikot RT, Zeng H, Yull FE, Li B, Cheng DS, Kernodle DS, Jansen ED, Contag CH, Segal BH, Holland SM et al (2004) p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol 172: 1801–1808

    PubMed  CAS  Google Scholar 

  57. Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT et al (2004) The knockout mouse project. Nat Genet 36: 921–924

    Article  PubMed  CAS  Google Scholar 

  58. Auwerx J, Avner P, Baldock R, Ballabio A, Balling R, Barbacid M, Berns A, Bradley A, Brown S, Carmeliet P et al (2004) The European dimension for the mouse genome mutagenesis program. Nat Genet 36: 925–927

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Novartis Institute of Biomedical Research, 4002, Basel, Switzerland

    Matthias Müller

  2. Novartis Institute for Biomedical Research, 100 Technology Square, Cambridge, MA, USA

    Nicole Avitahl-Curtis

Authors
  1. Matthias Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicole Avitahl-Curtis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Novartis Institutes for Biomedical Research Respiratory Disease Area, Novartis Horsham Research Centre, Wimblehurst Road, Horsham, West Sussex, UK

    Christopher S. Stevenson

  2. Johnson and Johnson PRD, Welsh & McKean Rd, Spring House, PA, 19477, USA

    Lisa A. Marshall

  3. Portfolio, Program and Alliance Management BiogenIdec, 14 Cambridge Center, Cambridge, MA, 02142, USA

    Douglas W. Morgan

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Müller, M., Avitahl-Curtis, N. (2006). Transgenics. In: Stevenson, C.S., Marshall, L.A., Morgan, D.W. (eds) In Vivo Models of Inflammation. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7520-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-7643-7520-1_7

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-7643-7519-5

  • Online ISBN: 978-3-7643-7520-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation